Chlormerodrin
Names | |
---|---|
IUPAC name 3-carbamoylamino-2-methoxypropylmercury(II) chloride | |
Systematic IUPAC name 3-chloro-mercura-2-methoxy propylurea | |
Other names
| |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ECHA InfoCard | 100.000.483 |
PubChem CID |
|
| |
Properties | |
Chemical formula | C5H11ClHgN2O2 |
Molar mass | 367.20 g·mol−1 |
Appearance | Solid |
Melting point | 152.5 °C (306.5 °F; 425.6 K) |
Solubility in water | 11 g/L |
Hazards | |
Occupational safety and health (OHS/OSH): | |
Main hazards | Renal mercury poisoning |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references |
Chemical compound
Clinical data | |
---|---|
AHFS/Drugs.com | Medical Encyclopedia |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
ChEBI |
|
ChEMBL |
|
ECHA InfoCard | 100.000.483 |
Chemical and physical data | |
Formula | C5H11ClHgN2O2 |
Molar mass | 367.20 g·mol−1 |
3D model (JSmol) |
|
| |
|
Chlormerodrin is a mercurial diuretic commercially traded from 1952[1] until 1974[2] that was once used to treat patients with heart failure,[3] but is no longer in widespread use.[4] The radiolabelled form (197Hg & 203Hg) had also been used for medical imaging of the kidney and brain[5][6] and the 197Hg form was even considered a contender for 99mTc by some physicians,[7] but was ultimately discontinued by the FDA in 1989.[8]
References
- ^ Sittig M (1988). Pharmaceutical Manufacturing Encyclopedia. Westwood: Noyes Publications.
- ^ Crout JR (1974). "Fixed combination prescription drugs: FDA policy". Journal of Clinical Pharmacology. 14 (5–6): 249–254. doi:10.1002/j.1552-4604.1974.tb02309.x. PMID 4829517. S2CID 5830209.
- ^ Leff WA, Nussbaum HE (April 1959). "Chlormerodrin: clinical effectiveness and absence of toxicity in congestive heart failure; report of a four-year study". British Medical Journal. 1 (5126): 883–889. doi:10.1136/bmj.1.5126.883. PMC 1992943. PMID 13629153.
- ^ "Chlormerodrin". PubChem. U.S. National Library of Medicine. Retrieved 2021-09-23.
- ^ Sodee DB, Di Stefano B (September 1965). "The Clinical Value of Today's Radioisotope Scanning". The Ohio State Medical Journal. 61: 819–22. PMID 14340215.
- ^ Yamamoto YL, Feindel W, Zanelli J (September 1964). "Comparative study of radioactive chlormerodrin (Neohydrin) tagged with mercury 197 and mercury 203 for brain scanning". Neurology. 14 (9): 815–820. doi:10.1212/wnl.14.9.815. PMID 14215595. S2CID 43526449.
- ^ Sodee DB (December 1968). "Comparison of 99mTc-pertechnetate and 197Hg-chlormerodrin for brain scanning". Journal of Nuclear Medicine. 9 (12): 645. PMID 5729215.
- ^ FDA, Approved Drug Products with Therapeutic Equivalence Evaluations, US Department Of Health And Human Service, 1989.
- v
- t
- e
(and etacrynic acid)
CA inhibitors (at PT) | |
---|---|
Loop (Na-K-Cl at AL) | |
Thiazides (Na-Cl at DCT, Calcium-sparing) | |
Thiazide-likes (primarily DCT) |
ESC blockers | |
---|---|
Aldosterone antagonists |
(DCT and CD)
- Ethanol, Isopropanol, 2M2B
- mercurial diuretics (Chlormerodrin, Mersalyl, Meralluride)
- Theobromine
- Cicletanine
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e